This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Gerald M. Lawrie, MD

JAMA. 1988;259(6):892-893.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In this issue of THE JOURNAL, DeVries¹ reports the clinical courses of four patients in whom Jarvik-7 total artificial heart (TAH) prostheses were implanted as permanent cardiac substitutes. All four patients subsequently suffered serious complications; despite these, three patients achieved survival with the TAH for intervals of 112, 488, and 620 days.

The Jarvik-7 prosthesis is a direct descendant of the early series of pneumatically driven TAH prostheses developed by Willem Kolff, MD, and colleagues working first at The Cleveland Clinic and later at the University of Utah.² In February 1963, Michael E. DeBakey, MD, proposed that the federal government support an organized program to develop a TAH.³ Established at the National Institutes of Health in 1964, the Artificial Heart Program had as its goals the development of a broad spectrum of devices for short-term circulatory and longterm ventricular assistance as well as the development of TAH . . . [Full Text PDF of this Article]

Author Affiliations
Baylor College of Medicine The Methodist Hospital Houston

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?